PKM and neoplasm: Taken together, our findings demonstrate that NONO interacts with nuclear PKM2 and directs histone H3 phosphorylation to promote tumor metastasis, highlighting the potential of disrupting the association between NONO and PKM2 for the targeted therapy of malignant TNBC.